First Time Loading...

Getein Biotech Inc
SSE:603387

Watchlist Manager
Getein Biotech Inc Logo
Getein Biotech Inc
SSE:603387
Watchlist
Price: 9.93 CNY 0.81% Market Closed
Updated: May 9, 2024

Wall Street
Price Targets

Price Targets Summary
Getein Biotech Inc

Wall Street analysts forecast Getein Biotech Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Getein Biotech Inc is 37.4 CNY .

Lowest
Price Target
Not Available
Average
Price Target
37.4 CNY
277% Upside
Highest
Price Target
Not Available
Getein Biotech Inc Competitors:
Price Targets
TSVT
2Seventy Bio Inc
152% Upside
AFMD
Affimed NV
353% Upside
300009
Anhui Anke Biotechnology Group Co Ltd
77% Upside
IOVA
Iovance Biotherapeutics Inc
98% Upside
688363
Bloomage Biotechnology Corp Ltd
16% Upside
002880
Shenzhen Weiguang Biological Products Co Ltd
24% Upside
CDMO
Avid Bioservices Inc
54% Upside
VICO
Vicore Pharma Holding AB
190% Upside

Revenue
Forecast

Revenue Estimate
Getein Biotech Inc

For the last 7 years the compound annual growth rate for Getein Biotech Inc's revenue is 31%. The projected CAGR for the next 3 years is 4%.

31%
Past Growth
4%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Getein Biotech Inc

Operating Income forecast
is not available for
Getein Biotech Inc

Net Income
Forecast

Net Income Estimate
Getein Biotech Inc

For the last 7 years the compound annual growth rate for Getein Biotech Inc's net income is 25%. The projected CAGR for the next 3 years is 1%.

25%
Past Growth
1%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Getein Biotech Inc's stock price target?
Price Target
37.4 CNY

According to Wall Street analysts, the average 1-year price target for Getein Biotech Inc is 37.4 CNY .

What is Getein Biotech Inc's Revenue forecast?
Projected CAGR
4%

For the last 7 years the compound annual growth rate for Getein Biotech Inc's revenue is 31%. The projected CAGR for the next 3 years is 4%.

What is Getein Biotech Inc's Net Income forecast?
Projected CAGR
1%

For the last 7 years the compound annual growth rate for Getein Biotech Inc's net income is 25%. The projected CAGR for the next 3 years is 1%.